Estimaciones de analistas de Wall Street para Sana Biotechnology, Inc. (SANA): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-05 | $-0.18 | ||
| 2026-08-11 | $-0.22 | $-0.15 | -49.8% |
| 2026-05-11 | $-0.14 | $-0.15 | +6.7% |
| 2026-03-03 | $-0.16 | $-0.13 | -23.1% |
| 2025-11-06 | $-0.15 | $-0.18 | +16.7% |
| 2025-08-11 | $-0.39 | $-0.20 | -95.0% |
| 2025-05-08 | $-0.20 | $-0.22 | +9.1% |
| 2025-03-17 | $-0.23 | $-0.25 | +8.0% |
Ratios de valoración
| Precio / Valor contable | 5.00 |
| EV / EBITDA | -4.36 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $1000 | $3.9M | $10.2M | 0 | 0 | 0 | 0 | $12.8M |
| Beneficio Bruto | -$1000 | -$3.9M | -$10.2M | 0 | 0 | 0 | 0 | -$12.8M |
| I+D | $4.0M | $119.4M | $122.7M | $306.5M | $201.0M | $219.8M | $208.7M | $132.0M |
| Generales y Administrativos | $4.2M | $21.8M | $28.3M | $50.4M | $71.6M | $73.3M | $64.0M | $44.3M |
| Gastos Operativos | $8.2M | $141.2M | $151.0M | $356.9M | $272.6M | $293.1M | $272.7M | $178.2M |
| Beneficio Operativo | -$8.2M | -$141.2M | -$161.1M | -$356.9M | -$272.6M | -$293.1M | -$272.7M | -$191.0M |
| EBITDA | -$13.2M | -$138.9M | -$287.0M | -$344.9M | -$253.9M | -$258.7M | -$249.4M | -$231.4M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$13.2M | -$138.3M | -$297.2M | -$355.9M | -$269.5M | -$283.3M | -$266.8M | -$244.2M |
| Impuestos | 0 | -$7.5M | -$11.9M | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$13.2M | -$130.8M | -$285.3M | -$355.9M | -$269.5M | -$283.3M | -$266.8M | -$244.2M |
| BPA | $-0.07 | $-0.70 | $-1.63 | $-2.14 | $-1.43 | $-1.46 | $-1.16 | $-0.96 |
| BPA Diluido | $-0.07 | $-0.70 | $-1.63 | $-2.14 | $-1.43 | $-1.46 | $-1.16 | $-0.96 |
| Acciones en Circulación (Diluidas) | $187.3M | $187.3M | $187.5M | $166.4M | $188.3M | $194.5M | $230.9M | $253.2M |
Precio
| Precio | $2.92 |
| Capitalización | $813M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: DNTH · INBX · KOD · NKTR · NRIX · OCS · PHAT
Explorar sector: Healthcare · Biotechnology
Más secciones de SANA: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones